{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T12:34:07Z","timestamp":1789907647258,"version":"4.0.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"48","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.vaccine.2014.09.018","type":"journal-article","created":{"date-parts":[[2014,9,22]],"date-time":"2014-09-22T16:16:53Z","timestamp":1411402613000},"page":"6499-6504","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Post-licensure surveillance of trivalent live attenuated influenza vaccine in adults, United States, Vaccine Adverse Event Reporting System (VAERS), July 2005\u2013June 2013"],"prefix":"10.1016","volume":"32","author":[{"given":"Penina","family":"Haber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro L.","family":"Moro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael M.","family":"McNeil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paige","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily Jane","family":"Woo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayley","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom T.","family":"Shimabukuro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2014.09.018_bib0005","unstructured":"Food and Drug Administration. June 17, 2003 approval letter-Influenza virus vaccine lives intranasal. \u3008http:\/\/www.fda.gov\/BiologicsBloodVaccines\/Vaccines\/ApprovedProducts\/ucm123753.htm\u3009 [accessed February 2014]."},{"issue":"RR-13","key":"10.1016\/j.vaccine.2014.09.018_bib0010","first-page":"1","article-title":"Using live, attenuated influenza vaccine for prevention and control of influenza. Supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"52","author":"Harper","year":"2003","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.vaccine.2014.09.018_bib0015","unstructured":"MedImmune, INC. FluMist\u00ae Package Insert (circular). \u3008http:\/\/www.medimmune.com\/docs\/default-source\/pdfs\/flumist_pi.pdf (accessed September 2013)"},{"key":"10.1016\/j.vaccine.2014.09.018_bib0020","first-page":"3","article-title":"Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"53","author":"Centers for Disease Control and Prevention","year":"2004","journal-title":"MMWR"},{"issue":"46","key":"10.1016\/j.vaccine.2014.09.018_bib0025","first-page":"1217","article-title":"Notice to readers: expansion of use of live attenuated influenza vaccine (FluMist) to children aged 2\u20134 years and other FluMist changes for 2007\u201308 influenza season","volume":"56","author":"Centers for Disease Control and Prevention","year":"2007","journal-title":"MMWR"},{"issue":"32","key":"10.1016\/j.vaccine.2014.09.018_bib0030","first-page":"691","article-title":"Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP)\u2014United States, 2014\u201315","volume":"63","author":"Centers for Disease Control and Prevention","year":"2014","journal-title":"Influenza Season MMWR"},{"key":"10.1016\/j.vaccine.2014.09.018_bib0035","unstructured":"Centers for Disease Control and Prevention. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR Recomm Rep 2009;58(RR-8):1\u20138."},{"issue":"RR-8","key":"10.1016\/j.vaccine.2014.09.018_bib0040","first-page":"1","article-title":"Centers for Disease Control and Prevention (CDC). Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"59","author":"Fiore","year":"2010","journal-title":"2010. MMWR Recomm Rep"},{"key":"10.1016\/j.vaccine.2014.09.018_bib0045","doi-asserted-by":"crossref","first-page":"9391","DOI":"10.1016\/j.vaccine.2011.09.109","article-title":"A randomized double-blinded noninferiority study of Quadrivalent live attenuated influenza vaccine in adults","volume":"29","author":"Block","year":"2011","journal-title":"Vaccine"},{"issue":"RR-07","key":"10.1016\/j.vaccine.2014.09.018_bib0050","first-page":"1","article-title":"Centers for Disease Control and Prevention (CDC). Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), - United States, 2013\u20132014.","volume":"62","author":"Grohskopf","year":"2013","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.vaccine.2014.09.018_bib0055","unstructured":"Food and Drug Administration. FluMist\u00ae Quadrivalent (Influenza Vaccine Live, Intranasal). \u3008http:\/\/www.fda.gov\/downloads\/BiologicsBloodVaccines\/Vaccines\/ApprovedProducts\/UCM294307.pdf\u3009 [accessed 2.07.12]."},{"issue":"11","key":"10.1016\/j.vaccine.2014.09.018_bib0060","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1586\/erv.12.108","article-title":"Quadrivalent Ann Arbor strain live-attenuated influenza vaccine","volume":"11","author":"Toback","year":"2012","journal-title":"Expert Rev Vaccines"},{"issue":"21","key":"10.1016\/j.vaccine.2014.09.018_bib0065","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1001\/jama.294.21.2720","article-title":"Adverse events reported following live cold-adapted intranasal influenza vaccine","volume":"294","author":"Izurieta","year":"2005","journal-title":"J Am Med Assoc"},{"issue":"4","key":"10.1016\/j.vaccine.2014.09.018_bib0070","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/00006454-200404000-00002","article-title":"Understanding vaccine safety information from the Vaccine Adverse Event Reporting System","volume":"23","author":"Varricchio","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2014.09.018_bib0075","series-title":"Post-licensure surveillance of trivalent live attenuated influenza vaccine in children aged 2\u201318 years","author":"Haber","year":"2005"},{"issue":"1 (Jan 24)","key":"10.1016\/j.vaccine.2014.09.018_bib0080","first-page":"1","article-title":"Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS) United States, 1991\u20132001","volume":"52","author":"Zhou","year":"2003","journal-title":"MMWR Surveill Summ"},{"key":"10.1016\/j.vaccine.2014.09.018_bib0085","unstructured":"Medical Dictionary for Regulatory Activities. \u3008http:\/\/www.meddramsso.com\u3009 [accessed 13.02.13]."},{"key":"10.1016\/j.vaccine.2014.09.018_bib0090","unstructured":"Code of Federal Regulations. 21 CFR \u00a7600.80. Revised April 1, 2010. \u3008http:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfcfr\/CFRSearch.cfm?fr=600.80\u3009."},{"key":"10.1016\/j.vaccine.2014.09.018_bib0095","doi-asserted-by":"crossref","first-page":"7248","DOI":"10.1016\/j.vaccine.2010.09.021","article-title":"Adverse events following influenza A (H1N1) 2009 monovalent vaccines reported to the Vaccine Adverse Event Reporting System, United States, October 1, 2009\u2013January 31, 2010","volume":"28","author":"Vellozzi","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.09.018_bib0100","unstructured":"National Health Interview Survey. \u3008http:\/\/www.cdc.gov\/nchs\/nhis.htm\u3009 [accessed June 13, 2013]."},{"key":"10.1016\/j.vaccine.2014.09.018_bib0105","unstructured":"United States Government Census report. \u3008https:\/\/www.census.gov\u3009 [accessed November 2013]."},{"key":"10.1016\/j.vaccine.2014.09.018_bib0110","doi-asserted-by":"crossref","first-page":"5675","DOI":"10.1016\/j.vaccine.2007.02.064","article-title":"Anaphylaxis: case definition and guidelines for data collection, analysis, and presentation of immunization safety data","volume":"25","author":"Ruggeberg","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.09.018_bib0115","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.vaccine.2010.06.003","article-title":"Guillain\u2013Barr\u00e9 syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data","volume":"29","author":"Sejvar","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.09.018_bib0120","series-title":"Proceeding of the conference on knowledge discovery and data","first-page":"67","article-title":"Empirical Bayes screening for multi-item associations","author":"DuMouchel","year":"2001"},{"key":"10.1016\/j.vaccine.2014.09.018_bib0125","doi-asserted-by":"crossref","first-page":"381","DOI":"10.2165\/00002018-200225060-00001","article-title":"Use of screening algorithms and computer systems to efficiently signal higher-than-expected combinations of drugs and events in the US FDA's Spontaneous Reports database","volume":"25","author":"Szarfman","year":"2002","journal-title":"Drug Saf"},{"key":"10.1016\/j.vaccine.2014.09.018_bib0130","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.vaccine.2012.12.028","article-title":"The safety and effectiveness of self-administration of intranasal live attenuated influenza vaccine in adults","volume":"31","author":"Ambrose","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.09.018_bib0135","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.1016\/j.vaccine.2012.02.080","article-title":"A postmarketing evaluation of the safety of Ann Arbor strain live attenuated influenza vaccine in adults 18\u201349 years of age","volume":"30","author":"Baxter","year":"2012","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2014.09.018_bib0140","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/oxfordjournals.aje.a112795","article-title":"Guillain\u2013Barr\u00e9 syndrome following vaccination in the National Influenza Immunization Program, United States, 1976\u20131977","volume":"110","author":"Schonberger","year":"1979","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2014.09.018_bib0145","series-title":"Adverse effects of vaccines: evidence and causality","year":"2011"},{"issue":"2","key":"10.1016\/j.vaccine.2014.09.018_bib0150","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1159\/000324710","article-title":"Population incidence of Guillain\u2013Barr\u00e9 syndrome: a systematic review and meta-analysis","volume":"36","author":"Sejvar","year":"2011","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.vaccine.2014.09.018_bib0155","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/1756-0500-2-171","article-title":"The epidemiology of Guillain\u2013Barr\u00e9 syndrome in U.S. military personnel: a case-control study","author":"Nelson","year":"2009","journal-title":"BMC Res Notes 2"},{"key":"10.1016\/j.vaccine.2014.09.018_bib0160","doi-asserted-by":"crossref","first-page":"435","DOI":"10.7205\/MILMED-D-13-00391","article-title":"Military healthcare providers reporting of adverse events following immunizations to the Vaccine Adverse Event Reporting System","volume":"179","author":"Li","year":"2014","journal-title":"Mil Med"},{"key":"10.1016\/j.vaccine.2014.09.018_bib0165","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1093\/aje\/kwh269","article-title":"Myopericarditis following smallpox vaccination","volume":"160","author":"Arness","year":"2004","journal-title":"Am J Epidemiol"},{"issue":"Suppl 3","key":"10.1016\/j.vaccine.2014.09.018_bib0170","doi-asserted-by":"crossref","first-page":"S242","DOI":"10.1086\/524747","article-title":"Myocarditis, pericarditis, and dilated cardiomyopathy after smallpox vaccination among civilians in the United States, January\u2013October 2003","volume":"46","author":"Morgan","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2014.09.018_bib0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2010.08.050","article-title":"Adverse events in pregnant women following administration of trivalent inactivated influenza vaccine and live attenuated influenza vaccine in the Vaccine Adverse Event Reporting System, 1990\u20132009","volume":"204","author":"Moro","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.vaccine.2014.09.018_bib0190","series-title":"Preventing Medication Errors: Quality Chasm Series","year":"2007"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14012778?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14012778?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,15]],"date-time":"2019-08-15T04:15:57Z","timestamp":1565842557000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X14012778"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":36,"journal-issue":{"issue":"48","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["S0264410X14012778"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.09.018","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Post-licensure surveillance of trivalent live attenuated influenza vaccine in adults, United States, Vaccine Adverse Event Reporting System (VAERS), July 2005\u2013June 2013","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.09.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}